The results demonstrated that the expression levels of CCNE1, E2F1, ARHGAP11A, RUNX1T1 and FES displayed significant correlation with the tumor stage in patients with NSCLC (Supplementary Figures S5A–E). The gene discussed is E2F1; the disease is non-small cell lung carcinoma.